Fundraising FoxMorphimmune
West Lafayette, US · Founded 2020 · Delaware corporation · 4 known investors
Find your way into Morphimmune
Sign up to see every warm intro you have to Morphimmune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Morphimmune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Morphimmune was founded in 2020 by Philip Low, Ph.D..
PL
Philip Low, Ph.D.Founder
SS
Sunil Singhal, M.D.Named on SEC filing
IB
CB
Clay B. Siegall, Ph.D.Named on SEC filing
RM
FP
Franklyn Prendergast, M.D., Ph.D.Named on SEC filing
Investors · 4
EcoR1 Capitallisted by EcoR1 CapitalSan Francisco
How we know: press coverage · Not right? Tell us
Janus Henderson InvestorsreportedLondon
How we know: press coverage · Not right? Tell us
REDMILEreportedSan Francisco
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$32.1M disclosed across 2 rounds · 2022–2023
▶$15MraisedMay 2023 · 11 investors · Other Health CareRule 506(b)
▶$15MraisedMay 2023 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sunil Singhal, M.D.Director
- Philip Low, Ph.D.Director
- Isaac BarchasDirector
- Clay B. Siegall, Ph.D.Executive Officer, Director
- Ronald MartellDirector
- Franklyn Prendergast, M.D., Ph.D.Director
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$17.1MraisedFeb 2022 · 18 investors · Other Health CareRule 506(b)
▶$17.1MraisedFeb 2022 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Isaac BarchasDirector
- Sunil Singhal, M.D.Director
- Philip Low, Ph.D.Director
- Ronald MartellExecutive Officer, Director
- Offering amount
- $19M
- Amount sold
- $17.1M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Morphimmune?
- Morphimmune was founded by Philip Low, Ph.D. in 2020.
- Who are Morphimmune's investors?
- Morphimmune's investors include EcoR1 Capital, Arsenal Bridge Venture, Janus Henderson Investors, REDMILE.
- How much funding has Morphimmune raised?
- Morphimmune has disclosed $32.1M raised across 2 rounds.
- Where is Morphimmune headquartered?
- Morphimmune is headquartered in West Lafayette, US.